Jepsen Jan Stenvang, Pfundheller Henrik M, Lykkesfeldt Anne E
Department of Tumor Endocrinology, Institute of Cancer Biology, Danish Cancer Society, DK-2100, Copenhagen, Denmark.
Oligonucleotides. 2004;14(2):147-56. doi: 10.1089/1545457041526281.
Locked nucleic acid (LNA) is a nucleic acid analog with very high affinity to complementary RNA and a promising compound in the field of antisense research. The intracellular localization and quantitative uptake of oligonucleotides containing LNA were found to be equivalent to those of phosphorothioate oligonucleotides (PS AONs). The antisense efficiency of LNA-containing oligonucleotides was systematically compared with standard PS AONs targeting expression of two endogenous proteins in the human breast cancer cell line MCF-7, namely, the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and the estrogen receptor alpha (ERalpha). For downregulation of both target proteins, the most efficient design was achieved with oligonucleotides containing LNA monomers in the extremities and a central gap of PS-linked DNA monomers, so called LNA gapmers. Such LNA gapmers caused more potent downregulation of the targeted proteins than PS AONs, whereas fully modified LNA AONs or LNA mixmers (LNA nucleotides interspersed) were inactive.
锁核酸(LNA)是一种对互补RNA具有极高亲和力的核酸类似物,是反义研究领域中一种很有前景的化合物。含有LNA的寡核苷酸在细胞内的定位和定量摄取情况被发现与硫代磷酸寡核苷酸(PS AONs)相当。在人乳腺癌细胞系MCF-7中,系统地比较了含有LNA的寡核苷酸与靶向两种内源性蛋白(细胞周期蛋白依赖性激酶抑制剂p21(WAF1/CIP1)和雌激素受体α(ERα))表达的标准PS AONs的反义效率。对于下调这两种靶蛋白,最有效的设计是在末端含有LNA单体且中间有PS连接的DNA单体的中心间隙的寡核苷酸,即所谓的LNA间隙嵌合体。这种LNA间隙嵌合体比PS AONs能更有效地下调靶蛋白,而完全修饰的LNA AONs或LNA混合嵌合体(LNA核苷酸穿插排列)则无活性。